melanoma

New challenges of melanomaMelanoma rates continue to rise, especially thin lesions which represents the largest group of fatalities. Gene expression profile tests can help diagnose or predict melanoma and are easy to use. But many dermatologists do not follow recommended treatment guidelines, which indicates a need to either educate practitioners or rethink the guidelines.
Diagnosing melanomaNewer tools to help diagnose challenging lesions include combined immunohistochemical stains and a growing array of genetic tests, one of which has shown the potential to gauge metastatic risk.
Motivating teens not to tan, on teens’ termsYou might be surprised about what researchers have uncovered about why teens tan. Having a better understanding of their motives, could help you help them.
Responding to melanoma’s growing threatMelanoma’s burden is increasing and the rising rates cannot simply be attributed to increased disease detection, according to a research letter published last month in JAMA Dermatology.
World-wide skin cancer epidemiologyThe incidence of melanoma appears to be on the rise except for that observed in the younger population, underscoring a positive trend and hope for the fight against skin cancer.
Research looks at melanocyte role in tumor formationWhile melanocytes have strong mechanisms for repair, those in individuals with certain risk factors may carry impaired repair responses. Studies have begun to examine melanocytes in patients at risk for developing melanoma with the hope of developing strategies for preventing deadly tumors.
Clinical acumen key for identifying pediatric melanomaExperts discuss diagnosis and management of pediatric melanoma, including the latest developments in genetic tools and indications for sentinel lymph node biopsy.
Clinical stage at diagnosis could affect melanoma survivalNYU researchers suggest a difference in the tumor progression of stage IV melanoma patients based on the initial clinical stage at original diagnosis.
Best practices for treating severe sun damageThe goal of treatment for severely sun-damaged patients’ lesions is field therapy, which not only treats what dermatologists see, but also subclinical disease.
New evidence supports combination therapy for metastatic melanomaEvidence-based data about molecular features is evolving to support the use of combination therapy as an option for treating metastatic melanoma.